The RH5.1/Matrix-M blood-stage vaccine could constitute a crucial secondary defence for communities at high risk of malaria infection, including those who have already received pre-erythrocytic vaccines, an analyst has…
First blood-stage malaria vaccine ‘a much-needed addition’ – analyst